1. Academic Validation
  2. GLUT1 deficiency syndrome in clinical practice

GLUT1 deficiency syndrome in clinical practice

  • Epilepsy Res. 2012 Jul;100(3):272-7. doi: 10.1016/j.eplepsyres.2011.02.007.
Joerg Klepper 1
Affiliations

Affiliation

  • 1 Childrens' Hospital Aschaffenburg, Am Hasenkopf, D-63739 Aschaffenburg, Germany. joerg.klepper@klinikum-aschaffenburg.de
Abstract

GLUT1 deficiency syndrome (GLUT1DS) is caused by impaired glucose transport into brain and is effectively treated by means of a ketogenic diet. In clinical practice the diagnosis of GLUT1DS often is challenging due to the increasing complexity of symptoms, diagnostic cut-offs for hypoglycorrhachia and genetic heterogeneity. In terms of treatment alternative ketogenic diets and their long-term side effects as well as novel compounds such as alpha-lipoic acid and triheptanoin have raised a variety of issues. The current diagnostic and therapeutic approach to GLUT1DS is discussed in this review in view of these recent developments.

Figures